SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Sep 23, 17:00
574.30
-20.3 (-3.41%)
VOLUME 186,625
LIVE
NSE
Sep 23, 17:00
573.80
-20.65 (-3.47%)
VOLUME 1,402,180

Stock Advice on Ranbaxy Laboratories

Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
Hold Sun Pharma; may test Rs 855-860: Akshata Deshmukh 

3.02 pm | 19 Sep 2014 |  Source: CNBC-TV18

Akshata Deshmukh of Networth Stock Broking is of the view that one may hold Sun Pharmaceutical Industries....

Buy Crompton, Ranbaxy; sell Rel Cap: Meghana Malkan 

1.37 pm | 18 Sep 2014 |  Source: CNBC-TV18

Meghana Malkan of malkansview.com is of the view that one may buy Ranbaxy Laboratories for a target price of Rs 615 and sell Reliance Capital for a ta...

Bull's Eye: Buy Siemens, Crompton, NBCC, Ranbaxy, Biocon 

8.46 am | 18 Sep 2014 |  Source: CNBC-TV18

Meghana V Malkan, malkansview.com advises buying Crompton Greaves for a target price of Rs 221 and Century Textiles for a target price of Rs 595....

Super Six buy or sell calls for September 18

8.24 am | 18 Sep 2014 |  Source: CNBC-TV18

Vishal Malkan of malkansview.com advises buying Ranbaxy Laboratories with a target of Rs 620-630 and Crompton Greaves with a target of Rs 222-226....

Buy Ranbaxy; sell Rel Cap, CESC, Adani Ent: Meghana Malkan 

1.58 pm | 17 Sep 2014 |  Source: CNBC-TV18

Meghana V Malkan of malkansview.com recommends selling Adani Enterprises with a target of Rs 475 and CESC with a target of Rs 748....

Bull's Eye: Buy Lupin, HDFC; short HDIL, Reliance Capital 

8.56 am | 17 Sep 2014 |  Source: CNBC-TV18

Meghana V Malkan, malkansview.com advises buying Ranbaxy Labs for a target price of Rs 615 and selling Reliance Capital for a target price of Rs 495....

Halol contributes 35-40% to Sun's US sales: Angel Broking  

10.54 am | 11 Sep 2014 |  Source: CNBC-TV18

Nangra believes that most pharma stocks are trading at fair valuations post the recent run-up in the market. She likes Dr Reddys and IPCA Labs in the ...

Jyotivardhan Jaipuria neutral on pharma space 

1.29 pm | 10 Sep 2014 |  Source: CNBC-TV18

Jyotivardhan Jaipuria, Head of Research, BofA ML is neutral on pharma space....

Buy Ranbaxy Laboratories, says Manas Jaiswal 

2.35 pm | 02 Sep 2014 |  Source: CNBC-TV18

Manas Jaiswal of manasjaiswal.com recommends buying Ranbaxy Laboratories as the stock may touch Rs 680 in next two to three trading sessions....

Hold Ranbaxy Lab; target Rs 750-770: Akshata Deshmukh 

4.44 pm | 22 Aug 2014 |  Source: CNBC-TV18

Akshata Deshmukh, Chief Strategist-Trading at Networth Stock Broking is of the view that one may hold Ranbaxy Laboratories with a target of Rs 750-770...

Checkout: What is PLilladher recommending in pharma space 

3.36 pm | 22 Aug 2014 |  Source: CNBC-TV18

Surajit Pal picks Glenmark as his top pharma bet among midcaps....

Stay with Ranbaxy Laboratories: Hemen Kapadia 

4.49 pm | 21 Aug 2014 |  Source: CNBC-TV18

Hemen Kapadia of KR Choksey Securities is of the view that one may hold Ranbaxy Laboratories....

Hold Ranbaxy Laboratories, says Ashu Madan 

3.36 pm | 21 Aug 2014 |  Source: CNBC-TV18

Ashu Madan of Religare Securities is of the view that one may hold Ranbaxy Laboratories....

Add Ranbaxy Laboratories, target Rs 650-660: Hemant Thukral 

11.17 am | 21 Aug 2014 |  Source: CNBC-TV18

Hemant Thukral of Aditya Birla Money recommends adding Ranbaxy Laboratories as the stock may head towards Rs 650-660....

Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.